KEI Comment on the Reduction of Number of Days the Public Can Comment on a Prospective NIH Exclusive Patent License

The National Institute of Health (NIH) recently held an all-day workshop titled, “Transforming Discoveries Into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer.” KEI Director James Love participated in the July 31st workshop, speaking on the panel on “How NIH… Continue Reading

KEI Questions to the NIH Regarding Prospective License of T-cell Cancer Therapy to EnZeta Immunotherapies

(Update: The NIH provided a response to our questions on August 17, 2023.) On August 11, 2023, Knowledge Ecology International (KEI) submitted questions to the National Institutes of Health regarding the “Prospective Grant of an Exclusive Patent License: Manufacture, Distribution,… Continue Reading

KEI Comments to the NIH Regarding the Prospective Grant of an Exclusive License to Elgia Therapeutics

On Friday August 4, 2023, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License: Development and Commercialization of Caspase Inhibitors” (88 FR 47152) to Elgia Therapeutics, Inc.… Continue Reading

WHA76: KEI statement on Strengthening WHO preparedness for and response to health emergencies

On Wednesday, 24 May 2023, Knowledge Ecology International (KEI) delivered a statement at the 76th World Health Assembly on Strengthening WHO preparedness for and response to health emergencies. WHO member states should make negotiations at the INB on a pandemic… Continue Reading

FTC asked to use its advocacy role in the Xtandi case

The U.S. Federal Trade Commission (FTC) mission “is protecting the public from deceptive or unfair business practices and from unfair methods of competition through law enforcement, advocacy, research, and education.” https://www.ftc.gov/about-ftc/mission The advocacy role of the FTC includes to “Advance… Continue Reading

NGO Letter to Biden Administration in Support of Xtandi Appeal

Today, eight non-governmental organizations sent the Biden Administration a letter of support for the administrative appeal of the request for the Department of Health and Human Services (HHS) to use its rights in the patents on the prostate cancer drug… Continue Reading

Reference Pricing in US Government COVID-19-related Contracts

Knowledge Ecology International conducted a review of contracts entered into by the US government concerning COVID-19-related treatments, diagnostics, vaccines, and other countermeasure-related technologies, regarding reference pricing clauses in the agreements. Of the 104 contracts reviewed, it is difficult to say… Continue Reading

Media coverage of the WHO pandemic treaty negotiations (on transparency and content) – First quarter, 2023

Media coverage of the WHO pandemic treaty negotiations (on transparency and content) – March/April 2023 2 February 2023, Reuters, Draft WHO pandemic deal pushes for equity to avoid COVID ‘failure’ repeat, By Jennifer Rigby and Gabrielle Tétrault-Farber. However, there will… Continue Reading